Biotronik Is Quietly Assembling a Spinal-Cord-Stim Challenge to the Big Four

Biotronik Is Quietly Assembling a Spinal-Cord-Stim Challenge to the Big Four

CI Neurology/Medtech/Neuromodulation Biotronik Is Quietly Assembling a Spinal-Cord-Stim Challenge to the Big Four Athithi Verma· 21 July 2026· 1 min read· Synopulse Biotronik Neuro launched Embrace One on 20 July, an AI capability for its Prospera spinal cord stimulation (SCS) system. It analyses more than 200 remote-monitoring data points per patient per day to flag … Read more

Tempus Buys Personalis for $1.5B to Own the MRD Layer It Already Sold

Tempus to acquire Personalis for $1.5B, buying the MRD test it already commercialised

Deal Oncology/ Diagnostics/ MRD Tempus Buys Personalis for $1.5B to Own the MRD Layer It Already Sold Athithi Verma· 21 July 2026· 1 min read· Synopulse Tempus AI will acquire Personalis at $16.25 per share, a $1.5B enterprise value net of the stake Tempus already held. All-stock, with a cash option capped at 50 percent. … Read more